
Global Microbiome Sequencing Market
Description
Report Scope
The report analyzes the microbiome sequencing market by component, sequencing technology, laboratory type, application and end user, offering insights into key trends and growth drivers. The study concludes with an analysis of leading companies and their offerings. The base year for the study is 2023, the estimated year is 2024 with projections through 2029, including compound annual growth rate (CAGR) for the forecast period.
This report analyzes the macroeconomic factors affecting the market. Market drivers, restraints and opportunities are identified. The report covers the regulatory landscape, recent technologies and patents in the market, as well as innovations in products and performance. The report also covers the competitive landscape, ESG factors and profiles of leading companies.
Regional analysis covers North America (U.S., Canada and Mexico), Europe (U.K., Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Middle East and Africa (MEA) and South America (Brazil, Argentina and Rest of South America).
Report Includes
Companies Mentioned
Baseclear Bv
Cd Genomics
Charles River Laboratories
Cosmosid
Crown Bioscience
Danaher Corp.
Eurofins Scientific
Illumina Inc.
Merieux Nutrisciences
Microbiome Insights
Novogene Co. Ltd.
Oxford Nanopore Technologies Plc
Pacbio
Qiagen
Thermo Fisher Scientific Inc.
The report analyzes the microbiome sequencing market by component, sequencing technology, laboratory type, application and end user, offering insights into key trends and growth drivers. The study concludes with an analysis of leading companies and their offerings. The base year for the study is 2023, the estimated year is 2024 with projections through 2029, including compound annual growth rate (CAGR) for the forecast period.
This report analyzes the macroeconomic factors affecting the market. Market drivers, restraints and opportunities are identified. The report covers the regulatory landscape, recent technologies and patents in the market, as well as innovations in products and performance. The report also covers the competitive landscape, ESG factors and profiles of leading companies.
Regional analysis covers North America (U.S., Canada and Mexico), Europe (U.K., Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Middle East and Africa (MEA) and South America (Brazil, Argentina and Rest of South America).
Report Includes
- 50 data tables and 51 additional tables
- Analyses of the global market trends for microbiome sequencing technologies, with revenue data from 2021-2024, and projected CAGRs through 2029
- Estimates of the size and revenue prospects for the global market, along with a market share analysis by sequencing technology, component, laboratory type, application, end user and region
- Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
- Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
- A look at the emerging trends and opportunities in microbiome-based therapeutics, clinical trials
- Evaluation of recent patent activity and key granted and published patents
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of leading companies including Illumina Inc., Qiagen, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Plc., and PacBio.
Companies Mentioned
Baseclear Bv
Cd Genomics
Charles River Laboratories
Cosmosid
Crown Bioscience
Danaher Corp.
Eurofins Scientific
Illumina Inc.
Merieux Nutrisciences
Microbiome Insights
Novogene Co. Ltd.
Oxford Nanopore Technologies Plc
Pacbio
Qiagen
Thermo Fisher Scientific Inc.
Table of Contents
124 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope Of Report
- Market Summary
- Chapter 2 Market Overview
- Overview
- Outlook
- Macroeconomic Analysis
- Impact Of U.S.-china Trade War
- Chapter 3 Market Dynamics
- Market Drivers
- Decreasing Cost Per Genome
- Government Initiatives And Funding
- Advances In Sequencing Technology
- Market Restraints
- Data Complexity And Bioinformatics Challenges
- Lack Of Standardized Protocols And Reference Databases
- Lack Of Grant Funding
- Market Opportunities
- Personalized Medicine And Diagnostics
- Drug Discovery And Development
- Agriculture And The Food Industry
- Chapter 4 Regulatory Landscape
- Overview
- Chapter 5 Emerging Technologies And Patent Analysis
- Emerging Technologies
- Nanopore Sequencing
- Smrt Sequencing
- Facs With Microfluidics
- Metatranscriptome Sequencing
- Patent Analysis
- Regional Patterns
- Chapter 6 Market Segment Analysis
- Market Trends
- Segmentation Breakdown
- Microbiome Sequencing: Global Markets
- Market Analysis By Sequencing Technology
- High-throughput Sequencing
- Sanger Sequencing
- Third-generation Sequencing
- Market Analysis By Component
- Reagents And Kits
- Instruments
- Market Analysis By Laboratory Type
- Wet Labs
- Dry Labs
- Market Analysis By Application
- Disease Diagnosis Research
- Personalized Medicine
- Drug Discovery
- Genetic Screening
- Other Applications
- Market Analysis By End User
- Pharmaceutical And Biotechnology
- Academic Centers And Research Institutes
- Other End Users
- Geographic Breakdown
- Market Breakdown By Region
- North America
- Europe
- Asia-pacific
- Mea
- South America
- Chapter 7 Competitive Landscape
- Key Suppliers And Manufacturers
- Ranking Of Companies In The Microbiome Sequencing Industry
- Strategic Analysis
- Chapter 8 Environmental, Social, And Governance (Esg) Perspective
- Sustainability In The Microbiome Sequencing Market
- Esg Risks And Ratings: Understanding The Data
- Bcc Research Viewpoint
- Chapter 9 Appendix
- Research Methodology
- Sources
- Abbreviations
- Company Profiles
- Baseclear Bv
- Cd Genomics
- Charles River Laboratories
- Cosmosid
- Crown Bioscience
- Danaher Corp.
- Eurofins Scientific
- Illumina Inc.
- Merieux Nutrisciences
- Microbiome Insights
- Novogene Co. Ltd.
- Oxford Nanopore Technologies Plc
- Pacbio
- Qiagen
- Thermo Fisher Scientific Inc.
- Emerging Startups
- Pendulum
- Microba
- Biomesense
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.